| Aantal gynaecologische carcinomen okt.’23- sept.’24 totaal |
111 NP =100; recidief:11 |
|
| Overig ; pre-mal., geen gyn carc. | 26 | |
| Mola | 7 | |
| AIS | 7 | |
| EIN | 8 | |
| Geen gyn ca. | 3 | |
| Endometriumcarc . totaal | 57 | |
| Stadium I | 43 | |
| Stadium II | ||
| Stadium III | 7 | |
| Stadium IV | 2 | |
| Onbekend | 1 | |
| GTN | 1 | |
| Recidief | 3 | |
| Ovariumcarc. totaal | 30 | |
| Stadium I | 6 | |
| Stadium II | 1 | |
| Stadium III | 7 | |
| Stadium IV | 4 | |
| Recidief | 3 | |
| Borderline | 9 | |
| Cervixcarc. totaal | 16 | |
| Stadium I | 7 | |
| Stadium II | 2 | |
| Stadium III | 3 | |
| Stadium IV | 4 | |
| Vulvacarc. totaal | 5 | |
| Stadium I | 2 | |
| Stadium III | 1 | |
| Recidief | 2 | |
| Vaginacarc. totaal | 2 | |
| Stadium I | 1 | |
| Stadium II | 1 | |
| Trofoblasttumoren | ||
| GTN | 1 | |
| mola | 7 |